An evaluation of the prescription of opioids for chronic nonmalignant pain by Australian general practitioners

- Holliday, Simon, Magin, Parker, Dunbabin, Janet, Oldmeadow, Christopher, Henry, Julie-Marie, Lintzeris, Nicholas, Attia, John, Goode, Susan, Dunlop, Adrian

An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy

- Holliday, Simon, Magin, Parker, Oldmeadow, Christopher, Attia, John, Dunbabin, Janet, Henry, Julie-Marie, Lintzeris, Nicholas, Goode, Susan, Dunlop, Adrian

Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series

- Nielsen, Suzanne, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa, Demirkol, Apo, Muhleisen, Peter, Lintzeris, Nicholas

Correlates of pain in an in-treatment sample of opioid-dependent people

- Nielsen, Suzanne, Larance, Briony, Lintzeris, Nicholas, Black, Emma, Bruno, Raimondo, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa

Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: the Opioid-Related Behaviours In Treatment (ORBIT) scale

- Larance, Briony, Bruno, Raimondo, Mattick, Richard P., Lintzeris, Nicholas, Degenhardt, Louise, Black, Emma, Brown, Amanda, Nielsen, Suzanne, Dunlop, Adrian, Holland, Rohan, Cohen, Milton

Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial

- Dunlop, Adrian J., Dunlop, AJ, Brown, AL, Oldmeadow, C, Attia, J, Harris, A, Ghijben, P, Sadler, C, Bell, J, Lintzeris, N, Brown, Amanda L., Hinman, Jennifer, Jackson, Melissa, Bell, James, Lintzeris, Nicholas, Oldmeadow, Christopher, Harris, Anthony, Gill, Anthony, Sadler, Craig, Ribbons, Karen, Attia, John, Barker, Daniel, Ghijben, Peter

Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field

- Sanson-Fisher, Rob, Brand, Matthew, Shakeshaft, Anthony, Haber, Paul, Day, Carolyn, Conigrave, Katherine, Mattick, Richard, Lintzeris, Nicholas, Teesson, Maree

Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder

- Frost, Michael, Bailey, Genie L., Oosman, Sonia, Kim, Sonnie, Tiberg, Fredrik, Lintzeris, Nicholas, Strang, John, Dunlop, Adrian, Nunes, Edward V., Jansen, Jakob Billeskov, Frey, Lars Chemnitz, Weber, Bernd, Haber, Pauk

Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial

- Allsop, David J., Copeland, Jan, Booth, Jessica, McGregor, Iain S., Lintzeris, Nicholas, Dunlop, Adrian J., Montebello, Mark, Sadler, Craig, Rivas, Gonzalo R., Holland, Rohan M., Muhleisen, Peter, Norberg, Melissa M.

Treating codeine dependence with buprenorphine: dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia

- Nielsen, Suzanne, Bruno, Raimondo, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa, Demirkol, Apo, Muhleisen, Peter, Lintzeris, Nicholas

Urinary cannabinoid levels during nabiximols (Sativex®)-medicated inpatient cannabis withdrawal

- Kevin, Richard C., Allsop, David J., Lintzeris, Nicholas, Dunlop, Adrian J., Booth, Jessica, McGregor, Iain S.

Validation and implementation of the Australian Treatment Outcomes Profile in specialist drug and alcohol settings

- Ryan, Anni, Holmes, Jennifer, Hunt, Vi, Dunlop, Adrian, Mammen, Kristie, Holland, Rohan, Sutton, Yvonne, Sindhusake, Doungkamol, Rivas, Gonzalo, Lintzeris, Nicholas